About Erica Joyner

This author has not yet filled in any details.
So far Erica Joyner has created 377 blog entries.

New York

On Tuesday, October 18, 2022, the New York State Department of Health (DOH) hosted a public online seminar about the transition of the pharmacy benefit from Medicaid Managed Care to NYRx, the Medicaid Fee-For-Service (FFS) pharmacy program. A copy of the presentation is now available. Valuable information and resources for Medicaid members and providers are also available on the DOH pharmacy transition website. Questions about the transition should be directed to NYRx@health.ny.gov. Please include “Pharmacy Benefit Transition” in the subject line.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-10-21T12:58:37-04:00October 21, 2022|New York|

Nebraska

On October 13, the Department of Health, and Human Services (HHS) posted the COVID-19 Fee Schedule Bivalent Booster Update.

Also in Nebraska, the HHS posted the Aducamumab (Aduhelm) prior authorization form for Fee-for-Service to its website.

Finally in Nebraska, the Credentialing Review (407) Program will meet on October 26 regarding Pharmacy Technicians. The agenda has been posted on the Credential Review (407) Pharmacy Technician webpage.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-10-21T12:57:34-04:00October 21, 2022|Nebraska|

Pennsylvania

Sen. Ryan Aument’s (R) bill allowing the Auditor General to conduct a full-scale audit of subcontracts with pharmacy benefit managers (PBMs) in Medicaid Managed Care unanimously passed the Senate Health and Human Services Committee this week and is expected to be considered by the full Senate next week.

Also in Pennsylvania, the Office of Medical Assistance Programs has issued a new bulletin regarding billing and payment for the Moderna SARS-CoV-2 Vaccine Booster. This bulletin as well as past bulletins can be found on DHS’ Bulletin search page.

Finally in Pennsylvania, the Board of Pharmacy has posted the agenda for the November 1 meeting.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-10-21T12:56:41-04:00October 21, 2022|Pennsylvania|

Tennessee

In collaboration with researchers at the UTHSC College of Pharmacy and grant support from Genentech, Tennessee Pharmacy Association would like to share an opportunity for community-based/outpatient pharmacies to enroll in a study investigating pharmacists’ management of influenza using point-of-care testing. Click here to learn more and enroll.

Also in Tennessee, updated versions of the Preferred Drug List (PDL), criteria PDL and interim criteria PDL are available, as well as the monthly provider notice for October 2022. Below is a summary of the updates:

  • The following agents will be added to the PDL as non-preferred:
    • Adlarity, Bylvay, Epsolay, Livmarli, Livtencity, Norliqva, Opzelura, Rezurock, Skytrofa, Tavneos, Tarpeyo, Triumeq PD
  • Clinical criteria and/or quantity limits will be updated for the following agents:
    • Nubeqa, Nucala, Olumiant, Skyrizi
  • The following agents will be added to the interim criteria PDL:
    • Radicava ORS, Vtama
  • Proventil HFA will be moved to preferred on the PDL in response to marketing discontinuation of Proair HFA

Updates to clinical criteria/quantity limits from the Q3 PAC meeting will also became effective on October 1 and were summarized in the September provider notice.

These documents are available on the TennCare website.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-10-21T12:55:51-04:00October 21, 2022|Tennessee|

Texas

The Board of Pharmacy’s posted the agenda for the November 1 meeting.

Also in Texas, save the date for the next PMP Advisory Committee remote Zoom meeting on December 1. Information will be posted on the Board of Pharmacy’s Committee & Task Force Meetings webpage as it becomes available.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-10-21T12:54:44-04:00October 21, 2022|Texas|

California

The Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal.

Also in California, Medi-Cal posted the following:

Also in California, the Board of Pharmacy posted its Board of Pharmacy Update – October 2022.

In California, Medi-Cal Rx will provide an educational opportunity regarding Brand Medically Necessary Prior Authorizations (DAW 1) and implications for pharmacy providers related to the Dispense as Written (DAW), Brand Medically Necessary (BMN), and Reimbursement – Frequently Asked Questions (FAQs) and Submission of Pricing Prior Authorization for Brand Medically Necessary Medications: Dispense as Written 1 (DAW1), released on September 29. Please join the Zoom meeting on October 10 at 1:00 p.m. Pacific using the following:

https://magellanhealth.zoom.us/j/93157317543?pwd=ZzlGRE9FNWtZWWtqb2FRZzcyMmE3Zz09&from=addon

Password: 924224

or iPhone one-tap (US Toll): +16699006833,93157317543# or +13462487799,93157317543#

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-10-07T10:55:31-04:00October 7, 2022|California|

Delaware

Governor John Carney (D) signed HB 399 authorizing a pharmacist to order, test, screen and treat certain health conditions pursuant to a statewide written protocol for CLIA-waived tests approved by the Division of Public Health. These health conditions include flu; Strep A; COVID or other respiratory illness, condition or disease; lice; skin conditions including ring worm and athlete’s foot or other emerging and existing public health threats identified and permitted by the Division of Public Health. A pharmacist may also delegate the administration and technical performance of the CLIA-waived test to an intern or pharmacy technician acting under the supervision of the pharmacist.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-10-07T10:54:15-04:00October 7, 2022|Delaware|

Florida

Due to Hurricane Ian, and effective immediately, retail food stores licensed by the Food and Nutrition Service and located in the State of Florida may accept SNAP benefits in exchange for HOT foods and foods intended to be consumed on retailer premises.

These special rules are in effect through October 31, 2022.

When hot foods are purchased with SNAP EBT benefits through October 31, 2022, the purchases are NOT subject to sales tax, as these foods are considered SNAP eligible during this period.

All SNAP authorized retail food stores in the State of Florida are encouraged to post a special notice in the store letting SNAP customers know that they can use their SNAP EBT benefits to purchase hot foods and, where practical, may remain on the premises to consume those foods.

Thank you for your assistance in aiding those impacted by Hurricane Ian.

Also in Florida, the state has Starlink Internet Provider units available to businesses. These are the portable wifi providers donated to the state by Elon Musk. Each unit can provide internet service to 2,000 square feet and can have 120 maximum concurrent devices connected at a time. Multiple units are available to primarily allow a business to have connectivity and secondly to provide hotspots to the public. The first priority is to assist businesses. The ESF in charge of this will assist with set up and provide technical support. Please contact Lorena@FRF.org for more information.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-10-07T11:14:00-04:00October 7, 2022|Florida|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top